Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes

INTRODUCTION: Glucagon-like peptide-1 (GLP-1) attenuates the glycaemic response to small intestinal nutrient infusion in stress-induced hyperglycaemia and reduces fasting glucose concentrations in critically ill patients with type-2 diabetes. The objective of this study was to evaluate the effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Deane, Adam M, Summers, Matthew J, Zaknic, Antony V, Chapman, Marianne J, Fraser, Robert JL, Di Bartolomeo, Anna E, Wishart, Judith M, Horowitz, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222072/
https://www.ncbi.nlm.nih.gov/pubmed/21255422
http://dx.doi.org/10.1186/cc9983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222072/
https://www.ncbi.nlm.nih.gov/pubmed/21255422
http://dx.doi.org/10.1186/cc9983

Ejemplares similares